Articles tagged with Chronic Obstructive Pulmonary Disease
Researchers found that patients treated with low-dose steroids orally had comparable outcomes to those given high-dose intravenous corticosteroids, with benefits including shorter hospital stays and lower costs. The study suggests that promoting the use of low-dose oral steroids could improve care for COPD patients
Researchers have developed a real-time wireless monitoring system to track vital signs of patients with debilitating conditions like Parkinson's disease and COPD. The system uses wearable sensors and a web portal for medical personnel to receive alerts in case of life-threatening events.
A study published in JAMA found that patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD) who received antibiotics within the first 2 hospital days had improved outcomes, including lower likelihood of mechanical ventilation and fewer readmissions. Antibiotics also reduced hospital costs.
A study of 2,230 patients with chronic obstructive pulmonary disease (COPD) found that long-term treatment with beta-blocker medications was associated with fewer respiratory flare-ups and longer survival. The study also showed that beta-blockers may reduce the risk of exacerbations in patients with COPD.
Neuromuscular electrical stimulation (NMES) may reduce muscle atrophy in patients with severe chronic obstructive pulmonary disease (COPD). NMES improved quadriceps and calf muscle mass, increasing the anabolism to catabolism ratio in muscle proteins.
A study found that pulmonary rehabilitation improves health status in COPD patients with varying levels of obesity, including those with extreme obesity. The research suggests that obese COPD patients may benefit from rehab despite lower exercise capacities.
A study published by the American Thoracic Society found that long-term vitamin E supplementation may decrease the risk of chronic obstructive pulmonary disease (COPD) by about 10% in both smokers and non-smokers. Vitamin E may protect lung tissue from damage caused by free radicals, according to researchers.
Research suggests that COPD patients who engage in higher amounts of daily physical activity have better functional exercise tolerance. Increasing normal daily activities like walking or gardening may be more beneficial than formal exercise training. This approach aims to promote a more active lifestyle and improve long-term function.
Researchers found vinpocetine reduces inflammation by targeting the activity of IKK, switching off NF-κB and producing pro-inflammatory molecules. The study shows great promise for vinpocetine as a novel anti-inflammatory agent with no severe side effects.
CanCOLD is a nationwide study to understand Chronic Obstructive Pulmonary Disease (COPD), improving its management and reducing its burden. The MUHC leads the pan-Canadian initiative, which aims to demystify COPD and improve public awareness.
A recent study found that nearly one in five adults aged 40+ with known COPD risk factors are undiagnosed, highlighting the need for early screening and intervention. The study's authors recommend targeting high-risk patients in primary care settings to reduce mortality, morbidity, and healthcare costs.
A new technique has been developed to reduce tobacco smoke damage to lungs in mice by blocking the GM-CSF protein. This research holds promise for identifying more effective therapies for cigarette smoke-induced lung damage.
The study analyzed data from 147 countries to identify factors that influence the time taken to introduce routine vaccination. Vaccine price and GAVI eligibility were found to be associated with quicker decisions to adopt vaccination, speeding up the process by 63% and 50%, respectively. Meanwhile, Dr. Peter Barnes discusses the growin...
Researchers found that pipe and cigar smoking is associated with decrements in lung function consistent with obstructive lung disease. HRT use also increases the risk of coronary heart disease, even after six years.
Researchers found that inhibiting sestrin protein improves lung elasticity and gas exchange in mice with emphysema. This suggests a new therapeutic approach to alleviate critical symptoms associated with COPD.
Researchers found strong links between mild COPD and diminished heart function in healthy adults, with the strongest association seen in current smokers and those with emphysema. The study's findings suggest that treating lung disease may improve heart function, but further research is needed.
A new study from Columbia University Medical Center researchers found that even mild cases of chronic obstructive pulmonary disease (COPD) can limit the heart's ability to pump effectively. The study, which involved over 2,800 adults, suggests a link between lung function and heart function.
Researchers discovered a genetic variant associated with preserved lung function in children with asthma and adults who smoke. The study found a significant reduction in the risk of developing chronic obstructive pulmonary disease (COPD) in adult smokers with this variant, offering new insights into the mechanisms of COPD.
A recent study by Michigan Medicine has found that dendritic cells, a type of immune cell, are more active in patients with severe COPD, leading to increased inflammation and disease progression. This research suggests that targeting dendritic cells may be a potential strategy for preventing COPD from worsening.
A new NIH-funded study has uncovered several DNA sequences linked to impaired pulmonary function, providing insight into mechanisms of lung capacity and potentially leading to better understanding of diseases like asthma and COPD. The findings may help develop new interventions to manage lung diseases and improve mortality rates.
Scientists have identified five genetic variants associated with lung health, providing new insights into the molecular basis of lung diseases. These findings hold promise for developing targeted treatments for conditions like Chronic Obstructive Pulmonary Disease (COPD) and asthma.
Research shows Italy's poor are more likely to be hospitalized with avoidable conditions, mirroring global patterns. Socio-economic disparities exacerbate the issue, particularly among males and those aged 45-64.
Scientists are using various imaging techniques, including MRI and CT scans, to study chronic obstructive pulmonary disease (COPD) and develop a better understanding of the disease. The research aims to categorize COPD patients into two major groups based on airway dysfunction and lung tissue damage.
Studies reveal an increasing number of ICU patients discharged home, while tele-ICUs reduce carbon footprint and costs. Excessive propofol use may lead to high omega-6 exposure, posing safety concerns. Abnormal sleep habits among ICU nurses may increase errors, but remote teleintensivist programs improve hospital mortality.
A new lung age formula more accurately calculates a smoker's 'lung age,' which researchers hope will help persuade patients to quit the habit. Pulmonary rehab programs also show promise in improving smoking cessation rates, with higher abstinence rates among participants.
Researchers found that increased ambient particulate matter levels are associated with increased ER visits for respiratory illness, while a new lung age formula more accurately calculates a smoker's 'lung age.' Pulmonary rehabilitation programs also showed higher abstinence rates among smokers with COPD.
A recent survey found that awareness of COPD is increasing, with 68% of adults aware of the disease. However, only 44% understand that it can be treated, and many at risk remain undiagnosed due to unrecognized symptoms. The NHLBI emphasizes the importance of testing and treatment for those affected.
Researchers have identified a genetic mutation linked to premature lung development and severe respiratory complications. The mutation, found in four children born with multiple abnormalities, may provide insight into potential treatments for newborn lung distress and COPD.
Researchers found that adding budesonide to tiotropium resulted in a 62% reduction in severe exacerbations and significant improvements in lung function, signs and symptoms, and quality of life. Triple therapy also improved morning activities and reduced hospitalizations.
Researchers will create a genetic and molecular treasure trove to redefine COPD and pulmonary fibrosis. The project aims to identify individuals at risk, diagnose earlier and develop personalized treatments.
Researchers at the University of Texas Health Science Center at Houston have linked osteopontin to COPD, a potentially novel approach to treatment. Elevated levels of osteopontin were found in people with COPD, suggesting it could serve as both an indicator and therapeutic target.
A new protein conjugate vaccine, PCV7, has been found to produce superior immune responses in patients with chronic obstructive pulmonary disease (COPD) compared to the currently accepted vaccine, PPSV23. The study suggests that PCV7 may offer improved protection against respiratory disease in COPD patients at risk for pneumonia.
Researchers developed an ADO index to help physicians assess COPD severity and determine appropriate treatment levels. The updated BODE index was also validated, showing improved accuracy in predicting patient mortality.
A new class of anti-inflammatory drugs called phosphodiesterase 4 (PDE4) inhibitors shows promise for improving lung function and reducing exacerbations in moderate-to-severe COPD patients. Roflumilast improved lung function by 48mL and reduced exacerbations by 17% compared to placebo, with more adverse events reported.
The UPLIFT study found that starting COPD treatment with inhaled tiotropium at an earlier stage reduces decline of lung function and risk of exacerbations. Treatment should begin in patients with moderate disease to improve health status.
A new predictive tool, ADO index, improves upon the existing BODE index by providing a more accurate estimate of mortality risk. The updated index is easier to use and can help clinicians identify patients at moderate or high risk of mortality, guiding targeted treatment options.
A new study published in The Lancet found that using inhaled corticosteroid budesonide to treat Chronic Obstructive Pulmonary Disease (COPD) does not significantly increase the risk of pneumonia. Data from over 7,000 patients showed a low incidence of pneumonia and no significant difference between treatment groups.
New research finds that mortality among patients with idiopathic pulmonary arterial hypertension (IPAH) awaiting lung transplant has not decreased, despite implementation of a new allocation system. The study suggests that key prognostic indicators in IPAH are not adequately captured by the current LAS algorithm.
Severe COPD is associated with significantly lower cognitive function in older adults, even after controlling for confounding factors. Patients with severe COPD are at greater risk for developing cognitive impairment, which can worsen their general health and quality of life.
A study found that high soy intake was associated with improved lung function and a lower risk of developing chronic obstructive pulmonary disease (COPD) in smokers. Flavonoids in soy may help protect against tobacco carcinogens, but more research is needed to understand the underlying mechanism.
A study published in the New England Journal of Medicine suggests that cigarette smoking does not affect everyone in the same way, with some people experiencing severe breathing difficulties while others evade the disease. The research proposes an autoimmune mechanism compounded by genetic predisposition as a possible explanation for t...
A lifestyle modification program for patients with mild to moderate COPD significantly improves health status, exercise capacity, and quality of life over a 2-year period. The program is also found to be cost-effective, despite initial higher costs.
Researchers found that calcitriol, a form of vitamin D, reduced growth-factor-induced airway smooth muscle proliferation in cells isolated from both asthmatic and non-asthmatic individuals. This process, called airway remodeling, leads to reduced lung function over time if left untreated.
A pooled analysis of two studies found significant improvements in pulmonary function, dyspnea, and rescue medication use when Perforomist Inhalation Solution was added to maintenance tiotropium. Patient satisfaction also increased with twice-daily Perforomist Inhalation Solution compared to ipratropium/albuterol metered-dose inhaler.
A new study suggests that women may be more vulnerable to the harmful effects of smoking due to smaller airways and gender differences in metabolism. The research analyzed data from a Norwegian case-control study, including 954 subjects with chronic obstructive pulmonary disease (COPD) and 955 controls.
The COPD Foundation's new Lung Health Check platform offers a quick assessment of breathing problems and provides personalized reports with suggestions for prevention and management. The resource aims to inform, educate, and empower individuals to take control of their lung health.
Researchers found that a self-treatment program for COPD patients led to fewer exacerbation days and increased medication use. This resulted in cost savings due to reduced hospitalizations and healthcare contacts. The study suggested that implementing such programs could help manage COPD effectively.
Data from two presentations will feature Perforomist Inhalation Solution, showing improved pulmonary function and dyspnea in patients with COPD when added to maintenance tiotropium. Patient satisfaction also increased in those treated with Perforomist twice daily compared to ipratropium/albuterol MDI
Researchers link muscle decline to elevated carbon dioxide in blood of patients with lung diseases, discovering surprising effects including increased lifespan and dynamic gene changes. High CO2 levels may impact treatment strategies for lung conditions.
Smoking both marijuana and tobacco significantly increases respiratory symptoms and chronic obstructive pulmonary disease (COPD) risk. A study of 878 adults aged 40 or older found that those who smoked both substances were 2.5 times more likely to have respiratory symptoms and almost 3 times more likely to have COPD.
Researchers found that cigarette smoke exposure alters the immune response to bacteria in mice, leading to increased inflammation and weight loss. This shift in inflammatory markers may impact treatment efficacy with corticosteroids for COPD patients.
Pulmonary rehabilitation improves aerobic function, reducing breathlessness in COPD patients. Supervised exercise also decreases anxiety and depression by enabling patients to master new skills.
Patients with moderate to severe COPD show altered breathing and swallowing coordination even during normal eating. The study found that COPD patients swallow more often at the end of exhalation, a pattern that disrupts safe swallowing.
Scientists at Duke University Medical Center have discovered two genetic markers that significantly increase the risk of developing chronic obstructive pulmonary disease (COPD) in smokers. These variants, located near a nicotine receptor, may be reduced by quitting smoking before COPD symptoms appear.
Researchers at Boston University School of Medicine identified a gene variant on chromosome 4 associated with an increased risk of COPD. The study, conducted in collaboration with the Framingham Heart Study, found that genetic factors play a role in susceptibility to cigarette smoke and impaired lung function.
Researchers found five single nucleotide polymorphisms (SNPs) in ADAM33 that were more frequent in COPD patients than non-COPD smokers. These polymorphisms, particularly S1, are associated with lung abnormalities and progressive decline in lung function characteristic of COPD.
New research shows individual COPD exacerbations increase repeat likelihood, driving disease progression. Patients may be 'brittle' during a subsequent eight-week period, requiring close monitoring and follow-up to prevent further exacerbations.
A new study from the University of Cincinnati finds that cigarette smoke can activate specific immune system receptors, leading to worsening of chronic obstructive pulmonary disorder (COPD) symptoms. The research identified a key cellular receptor, NKG2D, involved in this process.
New research finds that long-term use of inhaled corticosteroid drugs increases the risk of pneumonia in patients with Chronic Obstructive Pulmonary Disease (COPD). Analysis of 18 randomized clinical trials showed a significant association between corticosteroid inhaler use and pneumonia, with nearly one in every 47 patients developing...
Researchers found that activating Nrf2 can prevent emphysema in mice by reducing oxidative stress and improving lung function. The study suggests targeting Nrf2 could be a novel strategy for preventing chronic obstructive pulmonary disease (COPD).